Sumitomo Mitsui Ds Asset Management Company, LTD 10x Genomics, Inc. Transaction History

Sumitomo Mitsui Ds Asset Management Company, LTD

  • $7.99 Billion
  • Q1 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 13, 2022
SELL
$36.95 - $82.41 $148,760 - $331,782
-4,026 Closed
0 $0
Q3 2021

Oct 15, 2021
SELL
$145.58 - $192.14 $3,639 - $4,803
-25 Reduced 0.62%
4,026 $586,000
Q2 2021

Jul 19, 2021
BUY
$134.22 - $202.37 $78,787 - $118,791
587 Added 16.95%
4,051 $793,000
Q1 2021

May 07, 2021
BUY
$140.25 - $196.86 $4,628 - $6,496
33 Added 0.96%
3,464 $626,000
Q4 2020

Feb 02, 2021
BUY
$126.47 - $163.7 $433,918 - $561,654
3,431 New
3,431 $485,000

Others Institutions Holding TXG

# of Institutions
309
Shares Held
92M
Call Options Held
267K
Put Options Held
62.1K
View Full List

About 10x Genomics, Inc.

TXG Quotes by TradingView
  • Ticker TXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 95,046,400
  • Market Cap $1.79B
  • Description
  • 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...
More about TXG
Track This Portfolio

Track Sumitomo Mitsui Ds Asset Management Company, LTD Portfolio

Follow Sumitomo Mitsui Ds Asset Management Company, LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sumitomo Mitsui Ds Asset Management Company, LTD, based on Form 13F filings with the SEC.

News

Stay updated on Sumitomo Mitsui Ds Asset Management Company, LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email